These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 12707289)
1. Reduced growth factor responses in vascular smooth muscle cells derived from 12/15-lipoxygenase-deficient mice. Reddy MA; Kim YS; Lanting L; Natarajan R Hypertension; 2003 Jun; 41(6):1294-300. PubMed ID: 12707289 [TBL] [Abstract][Full Text] [Related]
2. Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice. Kim YS; Reddy MA; Lanting L; Adler SG; Natarajan R Kidney Int; 2003 Nov; 64(5):1702-14. PubMed ID: 14531803 [TBL] [Abstract][Full Text] [Related]
3. Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. Reddy MA; Adler SG; Kim YS; Lanting L; Rossi J; Kang SW; Nadler JL; Shahed A; Natarajan R Am J Physiol Renal Physiol; 2002 Nov; 283(5):F985-94. PubMed ID: 12372774 [TBL] [Abstract][Full Text] [Related]
4. The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotensin II effects. Reddy MA; Thimmalapura PR; Lanting L; Nadler JL; Fatima S; Natarajan R J Biol Chem; 2002 Mar; 277(12):9920-8. PubMed ID: 11786549 [TBL] [Abstract][Full Text] [Related]
5. Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells. Reddy MA; Sahar S; Villeneuve LM; Lanting L; Natarajan R Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):387-93. PubMed ID: 19095999 [TBL] [Abstract][Full Text] [Related]